• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Carl F. Ware receives ICIS Honorary Lifetime Membership Award

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

LA JOLLA, CALIF. – June 29, 2021 – Carl F. Ware, Ph.D., director of the Inflammatory Diseases Center at Sanford Burhnam Prebys, has received the 2021 International Cytokine & Interferon Society Honorary Lifetime Membership Award. The award is a tribute to his seminal and original contributions to our understanding of the role of cytokines in immunology and active engagement in cytokine research.

“It’s a tremendous honor to receive this prestigious award,” says Ware. “I’m grateful for the many outstanding scientists and students I’ve worked with over the years who have contributed to the field of cytokines. It’s especially gratifying to see how our discoveries are now being translated into much-needed therapies for infectious and inflammatory diseases–and even cancer.”

Ware began studying cytokines as a graduate student in the early 1970s. His decades-long career has produced many scientific breakthroughs, including the discoveries of several cytokines controlling immune defenses to viral infections. Recently, Ware showed that LIGHT levels are increased in COVID-19 patients progressing to pneumonia, which launched a Phase 2 trial using a LIGHT antibody that he developed.

With continuous support from the National Institutes of Health, Ware continues to investigate cytokine networks as a source of therapeutics for diseases without effective treatment. His work is providing new insights into immune evasion mechanisms and novel approaches to treat persistent viral infections. He is the holder of 18 patents, including one recently licensed to develop a new drug for patients with autoimmune diseases.

Among his several positions, he served with distinction as president of the International Cytokine Society and is on the scientific advisory board of the International Congress on TNF-related cytokines for many years. He has served on numerous advisory boards and study sections including the editorial board of the Journal of Interferon and Cytokine Research from 1996 to the present. In addition to his many scientific achievements, Ware has an outstanding record of mentorship with trainees who continue to shape the cytokine field all over the world.

###

About Sanford Burnham Prebys Medical Research Institute

Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Media Contact
Susan Gammon
[email protected]

Tags: BiologyBiotechnologyCell BiologyImmunology/Allergies/Asthma
Share12Tweet8Share2ShareShareShare2

Related Posts

Researchers Forge Innovative Paths in Immunotherapy for Cancer Treatment

Researchers Forge Innovative Paths in Immunotherapy for Cancer Treatment

October 8, 2025
Calm Red Brocket Deer Can Learn “Come” and Other Commands, While the Flightiest Struggle

Calm Red Brocket Deer Can Learn “Come” and Other Commands, While the Flightiest Struggle

October 8, 2025

Captive Bears and Pandas Exhibit Distinct Gut Microbiomes, with Giant Pandas Showing Reduced Microbial Diversity Compared to Wild Populations

October 8, 2025

Building a Core Collection for Cacao Diversity

October 8, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1116 shares
    Share 446 Tweet 279
  • New Study Reveals the Science Behind Exercise and Weight Loss

    100 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    79 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sex and Smoking Shape Bladder Mutation Patterns

Revolutionizing Object Detection: Global Influence and Trends

Research Lab Unveils Breakthrough in mRNA Cancer Vaccine Technology

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.